Cytoreductive surgery for metastatic gastrointestinal stromal tumors followed by sunitinib compared to followed by imatinib-a multi-center cohort study

Zhang Xinhua; Zhou Ye; Wu Xin; Nie Mingming; Zhang Bo; Zhou Yongjian; Sun Lifeng; Liu Zimin; Liu Xiufeng; Kou Youwei; Wang Yongpeng; Zhang Yefan; Hao Chunyi; Shen Lin; Li Jian

首页> 外文期刊>European Journal of Surgical Oncology: The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology >Cytoreductive surgery for metastatic gastrointestinal stromal tumors followed by sunitinib compared to followed by imatinib-a multi-center cohort study

【24h】

Cytoreductive surgery for metastatic gastrointestinal stromal tumors followed by sunitinib compared to followed by imatinib-a multi-center cohort study

机译：用于转移性胃肠肿瘤的细胞功能性手术，随后是伊替尼岛的桑顿 - 一种多中心队列研究

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background: The progression-free survival (PFS) is not optimal when imatinib was recommended for treatment of gastrointestinal stromal tumor (GIST) undergoing surgery after tumor local or multifocal progression.

机译：背景：当在肿瘤局部或多焦点后处理胃肠道基质肿瘤（GIST）治疗胃肠道间质瘤（GIST）时，无进展存活率（PFS）是不是最佳的。

著录项

来源
《European Journal of Surgical Oncology: The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 》 |2019年第3期| 共6页
作者
Zhang Xinhua; Zhou Ye; Wu Xin; Nie Mingming; Zhang Bo; Zhou Yongjian; Sun Lifeng; Liu Zimin; Liu Xiufeng; Kou Youwei; Wang Yongpeng; Zhang Yefan; Hao Chunyi; Shen Lin; Li Jian;
展开▼
作者单位

Sun Yat Sen Univ Dept Gastrointestinal Surg Affiliated Hosp 1 Guangzhou Guangdong Peoples R;

Fudan Univ Shanghai Canc Ctr Dept Gastr Surg Shanghai Peoples R China;

Peoples Liberat Army Gen Hosp Gen Surg Beijing Peoples R China;

Navy Mil Med Univ Shanghai Changhai Hosp Dept Gastrointestinal Surg Shanghai Peoples R China;

Sichuan Univ West China Hosp Gastrointestinal Surg Chengdu Sichuan Peoples R China;

Fujian Med Univ Union Hosp Dept Gastr Surg Fuzhou Fujian Peoples R China;

Zhejiang Univ Sch Med Affiliated Hosp 2 Dept Surg Oncol Hangzhou Zhejiang Peoples R China;

Qingdao Univ Affiliated Hosp Dept Oncol Qingdao Shandong Peoples R China;

Nanjing Univ Chinese Med Bayi Hosp Peoples Liberat Army Canc Ctr Nanjing Jiangsu Peoples R;

China Med Univ Shengjing Hosp Dept Gastrointestinal &

Nutriol Surg Shenyang Liaoning Peoples R;

Liaoning Canc Hosp &

Inst Dept Colorectal Surg Shenyang Liaoning Peoples R China;

Chinese Acad Med Sci Dept Hepatobiliary Surg Natl Canc Ctr Canc Hosp Beijing Peoples R China;

Peking Univ Beijing Canc Hosp &

Inst Lab Carcinogenesis &

Translat Res Dept Hepatobiliary Surg;

Peking Univ Beijing Canc Hosp &

Inst Lab Carcinogenesis &

Translat Res Dept GI Oncol Minist Educ;

Peking Univ Beijing Canc Hosp &

Inst Lab Carcinogenesis &

Translat Res Dept GI Oncol Minist Educ;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学 ;
关键词
Gastrointestinal stromal tumor; Tumor progression; Cytoreductive surgery; Sunitinib;

机译：胃肠道间质瘤;肿瘤进展;细胞渗透手术;桑顿;

相似文献

外文文献
中文文献
专利

1. Cytoreductive surgery for metastatic gastrointestinal stromal tumors followed by sunitinib compared to followed by imatinib-a multi-center cohort study [J] . Zhang Xinhua, Zhou Ye, Wu Xin, European Journal of Surgical Oncology: The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology . 2019 ,第3期

机译：用于转移性胃肠肿瘤的细胞功能性手术，随后是伊替尼岛的桑顿 - 一种多中心队列研究
2. Cytoreductive Surgery for Metastatic Gastrointestinal Stromal Tumors Treated With Tyrosine Kinase Inhibitors A 2-institutional Analysis [J] . Fairweather Mark, Balachandran Vinod P., Li George Z., Annals of Surgery . 2018 ,第2期

机译：用酪氨酸激酶抑制剂治疗转移性胃肠道基质肿瘤的细胞功能性手术A 2制度分析
3. 4526 POSTER Safety profile of single-agent sunitinib malate from the French Temporary Authorization for Use program (Cohort ATU) in metastatic renal cell carcinoma (MRCC) after failure of treatment with cytokines and gastrointestinal stromal tumor (GIST) patients after failure of imatinib mesylate treatment [J] . S.Oudard, S.Negrier, J.M.Ferrero, European Journal of Cancer Supplements . 2007 ,第4期

机译：4526 POSTER法国细胞因子和胃肠道间质瘤（GIST）治疗失败后，法国临时使用许可程序（Cohort ATU）单剂苹果酸舒尼替尼在转移性肾细胞癌（MRCC）中的安全性
4. Malignancy Prediction of Gastrointestinal Stromal Tumors by Evaluating Tumor Vessel Density from Enhanced Spiral CT Scan [C] . Jintao Li, Cihu Yu, Chang Li, International Conference on Communications, Information Management and Network Security . 2019

机译：通过增强螺旋CT扫描评价肿瘤血管密度的恶性肿瘤性质肿瘤
5. Roles of insulin-like growth factor binding protein-3 in gastrointestinal stromal tumors. [D] . Dupart, Jheri J. 2009

机译：胰岛素样生长因子结合蛋白3在胃肠道间质瘤中的作用。
6. Cytoreductive Surgery may be beneficial for highly selected patients with Metastatic Gastrointestinal Stromal Tumors receiving Regorafenib facing Local Progression: A Case Controlled Study [O] . Chun-Nan Yeh, Chia-Hsiang Hu, Shang-Yu Wang, 2021

机译：细胞功能性手术对于高度选择的胃肠道间质瘤患者可能是有益的接受局部进展的Regorafenib：一个案例控制研究
7. Imatinib dose escalation versus sunitinib as a second-line treatment against advanced gastrointestinal stromal tumors: A nationwide population-based cohort study [O] . Jun-Te Hsu, Puo-Hsien Le, Chang-Fu Kuo, 2017

机译：伊马替尼剂量升级与瑞伊替尼作为针对晚期胃肠肿瘤的二线治疗：全国范围的群体队列研究

Cytoreductive surgery for metastatic gastrointestinal stromal tumors followed by sunitinib compared to followed by imatinib-a multi-center cohort study

摘要

著录项

相似文献

相关主题

期刊订阅